PRP may be superior to hyaluronic acid for improvement of pain, function in patients with OA
[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” enable_mobile=”no” parallax_speed=”0.3″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” video_preview_image=”” border_size=”” border_color=”” border_style=”solid” margin_top=”” margin_bottom=”” padding_top=”” padding_right=”” padding_bottom=”” padding_left=””][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ spacing=”” center_content=”no” hover_type=”none” link=”” min_height=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”left top” background_repeat=”no-repeat” border_size=”0″ border_color=”” border_style=”solid” border_position=”all” padding=”” dimension_margin=”” animation_type=”” animation_direction=”left” animation_speed=”0.3″ animation_offset=”” last=”no”][fusion_text]
Use of intra-articular platelet-rich plasma significantly improved pain and function in patients with osteoarthritis at 6 months and may be a superior alternative to hyaluronic acid, according to study findings presented at the Arthroscopy Association of North America Annual Meeting.
“Our study suggests that lower-leukocyte [platelet-rich plasma] is … effective in the treatment of knee osteoarthritis, with superior and meaningful clinical differences in favor of [platelet-rich plasma] over [hyaluronic acid] at 6 months and 12 months,” Annemarie Tilton, BBA, said during her presentation.
[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container][fusion_builder_container admin_label=”” hundred_percent=”yes” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”#778899″ background_image=”” background_position=”left top” background_repeat=”no-repeat” fade=”no” background_parallax=”none” enable_mobile=”no” parallax_speed=”0.1″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” video_preview_image=”” border_size=”0″ border_color=”#707376″ border_style=”solid” margin_top=”” margin_bottom=”3%” padding_top=”80″ padding_right=”10%” padding_bottom=”80″ padding_left=”10%”][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” center_content=”no” last=”no” min_height=”” hover_type=”none” link=””][fusion_text]
Can PRP Injections Help You?
Platelet rich plasma cost with Dr. Verma is commonly priced at $750 per injection, or $2,000 for three injections if needed. Since PRP injections are still considered experimental, insurance does not cover the procedure. All procedures require cash payment.
[/fusion_text][/fusion_builder_column][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”no” center_content=”no” min_height=”none” last=”no” hover_type=”none” link=”” border_position=”all”][fusion_button link=”/contact-us/” color=”custom” size=”” stretch=”” type=”” shape=”” target=”_self” title=”” button_gradient_top_color=”#b55d5c” button_gradient_bottom_color=”#b55d5c” button_gradient_top_color_hover=”#b55d5c” button_gradient_bottom_color_hover=”#b55d5c” accent_color=”#ffffff” accent_hover_color=”#ffffff” bevel_color=”” border_width=”1px” icon=”” icon_divider=”yes” icon_position=”left” modal=”” animation_type=”0″ animation_direction=”down” animation_speed=”0.1″ animation_offset=”” alignment=”center” class=”” id=””]Request Case Review or Office Consultation[/fusion_button][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container][fusion_builder_container admin_label=”” hundred_percent=”no” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” enable_mobile=”no” parallax_speed=”0.3″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” video_preview_image=”” border_size=”” border_color=”” border_style=”solid” margin_top=”” margin_bottom=”5%” padding_top=”” padding_right=”” padding_bottom=”” padding_left=””][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ spacing=”” center_content=”no” hover_type=”none” link=”” min_height=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”left top” background_repeat=”no-repeat” border_size=”0″ border_color=”” border_style=”solid” border_position=”all” padding=”” dimension_margin=”” animation_type=”” animation_direction=”left” animation_speed=”0.3″ animation_offset=”” last=”no”][fusion_text]
Tilton and colleagues randomly assigned 99 patients with a minimum of 3 months of symptomatic unilateral knee osteoarthritis (OA) and Kellgren Lawrence grade 1-3 OA to receive 3 weekly injections of either platelet-rich plasma (PRP) or hyaluronic acid (HA). Patients completed Lysholm, IKDC, WOMAC and VAS pain surveys and underwent clinical examination at 6 weeks, 12 weeks and 24 weeks after index treatment. During each treatment visit and at 3-month and 6-month follow-up, patients also underwent ultrasound-guided knee aspiration for synovial fluid analysis.
According to Tilton, patients who had a low BMI, as well as patients with Kellgren Lawrence grade 1 OA, tended to be responders to treatment. Additionally, PRP fold was not found to be a factor in response to treatment.
Patients in the PRP group also had lower pain scores at 6 months and 1 year vs. the HA group, according to study results. At 3 months post-treatment, biologic outcomes showed the PRP group trended toward lower values of interleukin-1 beta and tumor necrosis factor-alpha. – by Casey Tingle
Reference:
Cole B, et al. Paper #SS-57. Presented at: Arthroscopy Association of North America Annual Meeting. April 23-25, 2015; Los Angeles.
Disclosure: Tilton reports no relevant financial disclosures.
[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]
